osteoarthritis

AstraZeneca and Pozen announced Monday that their pain reliever Vimovo for the treatment of arthritis had received positive agreement for approval by the 23 E.U. nations. Vimovo is a combination drug that reduces the risk of ulcers for frequent NSAID users.

Pfizer announced the suspension of clinical trials of its pain drug tanezumab in patients with osteoarthritis. The halt comes after several patients taking the drug experienced worsening of their condition, leading to joint replacement.

Amgen, the world's largest biotechnology company, reported fourth-quarter results that missed Wall Street's expectations, as a 2% increase in sales failed to translate into a stronger bottom line.

Runners spend $20 billion a year on running shoes, but is all the fancy footwear really a good investment? A new study finds that running shoes exert a lot more stress on key joints than running barefoot, potentially increasing a runner%u2019s risk of developing osteoarthritis.